1. Home
  2. PSTV vs UPXI Comparison

PSTV vs UPXI Comparison

Compare PSTV & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • UPXI
  • Stock Information
  • Founded
  • PSTV 1996
  • UPXI 2018
  • Country
  • PSTV United States
  • UPXI United States
  • Employees
  • PSTV N/A
  • UPXI N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • PSTV Health Care
  • UPXI Health Care
  • Exchange
  • PSTV Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • PSTV 10.4M
  • UPXI 356.9M
  • IPO Year
  • PSTV N/A
  • UPXI 2021
  • Fundamental
  • Price
  • PSTV $0.30
  • UPXI $3.25
  • Analyst Decision
  • PSTV Strong Buy
  • UPXI
  • Analyst Count
  • PSTV 3
  • UPXI 0
  • Target Price
  • PSTV $10.83
  • UPXI N/A
  • AVG Volume (30 Days)
  • PSTV 59.6M
  • UPXI 2.1M
  • Earning Date
  • PSTV 08-13-2025
  • UPXI 05-16-2025
  • Dividend Yield
  • PSTV N/A
  • UPXI N/A
  • EPS Growth
  • PSTV N/A
  • UPXI N/A
  • EPS
  • PSTV N/A
  • UPXI N/A
  • Revenue
  • PSTV $5,206,000.00
  • UPXI $16,562,327.00
  • Revenue This Year
  • PSTV $13.26
  • UPXI $299.03
  • Revenue Next Year
  • PSTV $8.84
  • UPXI N/A
  • P/E Ratio
  • PSTV N/A
  • UPXI N/A
  • Revenue Growth
  • PSTV N/A
  • UPXI 1378.83
  • 52 Week Low
  • PSTV $0.16
  • UPXI $1.90
  • 52 Week High
  • PSTV $2.31
  • UPXI $22.57
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 46.06
  • UPXI 30.45
  • Support Level
  • PSTV $0.30
  • UPXI $2.73
  • Resistance Level
  • PSTV $0.37
  • UPXI $3.07
  • Average True Range (ATR)
  • PSTV 0.05
  • UPXI 0.97
  • MACD
  • PSTV 0.02
  • UPXI -0.67
  • Stochastic Oscillator
  • PSTV 50.89
  • UPXI 4.98

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.

Share on Social Networks: